Aperio Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $2.32M | Buy |
16,791
+3,238
| +24% | +$448K | 0.01% | 1167 |
|
|
2020
Q3 | $1.11M | Buy |
13,553
+1,695
| +14% | +$139K | ﹤0.01% | 1387 |
|
|
2020
Q2 | $928K | Buy |
11,858
+2,747
| +30% | +$215K | ﹤0.01% | 1450 |
|
|
2020
Q1 | $405K | Buy |
9,111
+563
| +7% | +$25K | ﹤0.01% | 1755 |
|
|
2019
Q4 | $365K | Sell |
8,548
-982
| -10% | -$41.9K | ﹤0.01% | 1974 |
|
|
2019
Q3 | $408K | Buy |
9,530
+400
| +4% | +$17.1K | ﹤0.01% | 1869 |
|
|
2019
Q2 | $580K | Buy |
9,130
+1,608
| +21% | +$102K | ﹤0.01% | 1696 |
|
|
2019
Q1 | $522K | Buy |
7,522
+2,049
| +37% | +$142K | ﹤0.01% | 1731 |
|
|
2018
Q4 | $238K | Sell |
5,473
-123
| -2% | -$5.35K | ﹤0.01% | 2058 |
|
|
2018
Q3 | $427K | Buy |
5,596
+49
| +0.9% | +$3.74K | ﹤0.01% | 1849 |
|
|
2018
Q2 | $426K | Buy |
5,547
+472
| +9% | +$36.2K | ﹤0.01% | 1825 |
|
|
2018
Q1 | $259K | Sell |
5,075
-396
| -7% | -$20.2K | ﹤0.01% | 2027 |
|
|
2017
Q4 | $254K | Buy |
+5,471
| New | +$254K | ﹤0.01% | 2036 |
|
|
2017
Q3 | – | Sell |
-3,851
| Closed | -$239K | – | 2230 |
|
|
2017
Q2 | $239K | Buy |
3,851
+299
| +8% | +$18.6K | ﹤0.01% | 2021 |
|
|
2017
Q1 | $241K | Buy |
+3,552
| New | +$241K | ﹤0.01% | 1944 |
|